Haleon
HLN
9.02
+0.15
+1.69%
Haleon
US · HLN
#553 by market cap
Listed 2022
9.02
+0.15
+1.69%
Live - 5344 symbols - heartbeat 471s ago
· 2026-10-08 05:53
Pre-market
9.12
+1.11%
After-hours
9.02
0.00%
Overnight
9.07
+0.55%
- Market cap
- 39.67B
- P/E (TTM)i
- 18.87
- P/Bi
- 1.83
- EPSi
- 0.49
- Div yieldi
- 2.11%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on HLN?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 1 analysts
Buy
Avg price target
11.00 +22.0%
Price target rangecurrent 9.02
Low11.00
Avg11.00
High11.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (2)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-08-10 | Argus Research | -- | BUY | 11.00 |
| 2026-05-20 | Argus Research | -- | BUY | 11.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-30 | -- | ±9.76% | -1.65% (in line) |
| 2025/Q4 | 2026-02-25 | -- | -- | -5.78% |
| 2025/Q2 | 2025-07-31 | -- | ±12.29% | -2.18% (in line) |
| 2024/Q4 | 2025-02-27 | -- | ±5.88% | -4.02% (in line) |
| 2024/Q2 | 2024-08-01 | -- | ±15.05% | +1.97% (in line) |
| 2023/Q4 | 2024-02-29 | -- | ±8.81% | +6.20% (in line) |
| 2023/Q2 | 2023-08-02 | -- | ±27.72% | -2.69% (in line) |
| 2022/Q4 | 2023-03-02 | -- | ±7.20% | -3.66% (in line) |
| 2022/Q2 | 2022-09-20 | -- | -- | +1.35% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 05:53:08 · For reference only, not investment advice and not tailored to your situation.